‌

US Patent 10933034 Bupropion as a modulator of drug activity

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Herriot Tabuteau0

Date of Patent

March 2, 2021

0

Patent Application Number

170037770

Date Filed

August 26, 2020

0

Patent Citations

US Patent 10080727 Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects

US Patent 10092560 Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects

US Patent 10092561 Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan

US Patent 10105327 Compositions and methods for increasing the metabolic lifetime of dextromethorphane and related pharmacodynamic effects

US Patent 10105361 Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects

US Patent 10251879 Bupropion as a modulator of drug activity

US Patent 10463634 Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects

US Patent 10512643 Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects

...

Patent Citations Received

US Patent 12109178 Bupropion as a modulator of drug activity

0

US Patent 11497721 Bupropion as a modulator of drug activity

US Patent 11510918 Bupropion as a modulator of drug activity

US Patent 11517542 Bupropion as a modulator of drug activity

US Patent 11517544 Bupropion as a modulator of drug activity

US Patent 11517543 Bupropion as a modulator of drug activity

US Patent 11524007 Bupropion as a modulator of drug activity

US Patent 11524008 Bupropion as a modulator of drug activity

...

Patent Primary Examiner

0

Patent abstract

Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically, bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10933034 Bupropion as a modulator of drug activity

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.